NDT Pharmaceuticals Inc (NDTP)

[Ecomike]

OTCmarkets shows all that information.

It has a 15-12G SEC filing.

It filed an 8-K updating the plans

It paid 11 years of late Nevada fees and updated the officers, directors lists and phone number, and web site.

All that is left is cancelling the 15-12g and filling the SEC S-1/1-A filling to go back to fully reporting, and uplist to NYSE.

It has only been 11 trading days since we got our shares back, and the 2 months delay in returning shares was partly the TA's fault, not NDTP's fault. NDTP had fix the TA's goof, what little I think I know on that.

I think the COVID19 delays of the 10Ks and TA goofs, moved to a point where they are rushing to update the SEC S-1/1-A with 1-2 10-Qs now due to the COVID19 and TA goof delays. Pretty sure they must add at least the 1st qtr 10-Q now to do the filling for full re-registration of the shares.

And the 2nd quarter is due in weeks now. They could be changing the annual year basis and re-auditing on and end of June year basis for all I know, as the 15-12g and the expected SEC re-registration forces them to stay gaged for now.

The Attorney was hired weeks before the R/S and ticker change to package the SEC S-1/1-A filling.

Nevada was updated the end of May, just 8 weeks ago.

They could not do the SEC filling with out the name change and new ticker and new company name filed with FINRA and Nevada, and all that is only 8-2 weeks old.

They have made progress step by step.

If this was a scam, if they needed money, they would have already filled BS/Junk and done a punp-n-dump 4+ months ago.

The Custodian was only released by the Court to resign and turn the company over in May, 8 weeks ago.

They hired the attorney-counsel weeks later to prep a massive, probably 100 page S-1/1-A filing with 1-2 of financials of the Merged company.

They also needed to update the CCA, LLC (firm R/M with MILV to form NDTP) JV contract with Univ of Penn Medical research Hospital that also includes the Children's hospital, to be a contract with NDTP Nano delivery Technology Pharmaceuticals Inc., and that could not be done until 2 weeks ago when the all the above had been done and completed with out any remaining boxes to check off, like the Nevada update, the name change and ticker change with FINRA.

The slow deliberate pace, step by step by step by step progress tells me this is all real and is the mother of all Biotech births underway, as they are not in a rush for money. If they were they would have used Alternative reporting and run a scam. They did not.

I am buying more shares.

Here is the link to OTCmarkets for the current details. TA updated share data 2 days ago.

They can NOT legally PR, take the website live, or promote the stock until the SEC filing is delivered to the SEC, and the SEC 15-12g going silent period is over.

https://www.otcmarkets.com/stock/NDTP/profile

James Hovis is the new CEO, has been offically per Nevada for only 8 weeks now. He is the managing LLC shareholder of the Biotech R/M with what is now NDTP. His cell phone is listed on OTCMarkets as the company phone, but he is gagged until SEC S-1/1-A is filed.

This is the droid we have been looking for, and is the one worth waiting for.